A Double Blinded, Randomized Study Comparing the Effectiveness of Fish Oil Supplements, Oral Statins, and Placebo in Reducing the Incidence of Atrial Fibrillation Following a Lung Resection in Patients With Lung Cancer.

Trial Profile

A Double Blinded, Randomized Study Comparing the Effectiveness of Fish Oil Supplements, Oral Statins, and Placebo in Reducing the Incidence of Atrial Fibrillation Following a Lung Resection in Patients With Lung Cancer.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 06 Aug 2012

At a glance

  • Drugs Atorvastatin (Primary) ; Omega 3 fatty acids
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jul 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 31 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Aug 2011 New source identified and integrated M.D. Anderson Cancer Center record 2009-0591.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top